Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Conavi Medical Corp

CNVI.V ✗ NOT COMPLIANT ☆ Track — members

TSX Venture · Healthcare · Advanced Medical Equipment & Technology ·

Canada Micro Cap Analyst: N/A

Last Close

$0.15

▲ +5.13%

Market Cap $15.23M · Vol 2.68K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$15.23M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

68.18

Momentum

Beta

0.42

vs Market

52W High

$0.50

70.57% below

52W Low

$0.11

38.83% above

Volume

2.68K

Avg 96.78K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

67.37%

Public shares

Shariah Compliance8 STANDARDS

✗ Conavi Medical Corp (CNVI.V) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CNVI.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+5.13%

-6.82%

-26.79%

-51.19%

YTD

-54.95%

-56.15%

-95.80%

-99.60%

Financials & Valuation

TTM · Annual

Total Revenue	$6.55M
Net Income	$-14,738,506.00
Revenue Growth (YoY)	+124.14%
Gross Margin	74.70%
Operating Margin	-162.82%
Net Profit Margin	-224.91%
ROE	N/A
ROA · ROIC	-170.62% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	4.22
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	103.49M

Technical Indicators

50-Day SMA	$0.16
200-Day SMA	$0.28
RSI (14)	68.18
Beta	0.42
52-Week High	$0.50
52-Week Low	$0.11

Volume Today	2.68K
Avg Daily Volume (30D)	96.78K
Relative Volume	0.03x
Volatility (10D)	74.96
Volatility (30D)	104.36
Free Float	67.37%

Analyst Consensus

N/A

Current Price $0.15

Mean Target N/A

52W Low$0.11 52W High$0.50

Current

Target

$0.11 $0.50

Current Analyst target

· 0 analysts

Identifiers

ExchangeTSX Venture

FIGIBBG001SRP223

ISINCA2059531020

CountryCanada

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

Conavi Medical Corp. is a Canada-based medical device company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary interventions (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.